myofascial trigger points pain syndrome.
Conditions
Interventions
Intervention 1: Intervention group:The first group is treated with GA-AL-AS low power diode laser with a wavelength of 808 nm Konftec low power laser device made in Taiwan with a power of 250 ml watts
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 18 years The presence of a trigger point in the temporalis or master or external trigeminal muscles that are identified by touch and examination
Exclusion criteria
Exclusion criteria: Taking painkillers, muscle relaxants, anti-inflammatory drugs and benzodiazepines Fear of needles, cupping or lasers Bleeding disorders Any underlying diseases such as metabolic (diabetes) and vascular Neurological disorders (trigeminal neuralgia) Pregnancy Receive any treatment for temporomandibular joint disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Pain is recorded in the first session of the examination under VAS 1 and then in each treatment session at the beginning of the session before the start of the new treatment phase that day in the relevant schedule. The last amount of pain recording in the follow-up session is done 1 month after the completion of the treatment sessions as VAS 2 or Visit In 1 Month. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| (Maximum mouth opening). Timepoint: In the first session, the examination is called MMO 1 and each session is recorded in the relevant table before starting the treatment. The last MMO registration in the follow-up session is done 1 month after the completion of the treatment sessions as MMO2 or Visit In 1 Mouth. Method of measurement: By calibrated ruler in mm. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohammad Asnaashari
Shahid Beheshti University of Medical Sciences
Outcome results
None listed